267. Hyper-IgD syndrome Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 11 /  Drugs : 6 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 44

Hyper-IgD syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
IDDiseases (Sorted by drug repositionability)
267Hyper-IgD syndrome
13Multiple sclerosis/Neuromyelitis optica
34Neurofibromatosis
46Malignant rheumatoid arthritis
51Scleroderma
84Sarcoidosis
85Idiopathic interstitial pneumonia
222Primary nephrotic syndrome
228Bronchiolitis obliterans
113Muscular dystrophy
50Dermatomyositis
56Behcet disease
107Juvenile idiopathic arthritis
58Hypertrophic cardiomyopathy
164Oculocutaneous albinism
41Giant cell arteritis
269Pyogenic arthritis
106Cryopyrin-associated periodic syndrome
266Familial mediterranean fever
108TNF receptor-associated periodic syndrome